O. Bayturan, E. Tuzcu, A. Lavoie, T. Hu, K. Wolski et al., The Metabolic Syndrome, Its Component Risk Factors, and Progression of Coronary Atherosclerosis, Archives of Internal Medicine, vol.170, issue.5, pp.478-84, 2007.
DOI : 10.1001/archinternmed.2009.551

J. Ludwig, D. Mcgill, and K. Lindor, REVIEW: Nonalcoholic steatohepatitis, Journal of Gastroenterology and Hepatology, vol.4, issue.5, pp.398-403, 1997.
DOI : 10.1002/hep.1840110104

L. Boring, J. Gosling, M. Cleary, and I. Charo, Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis, Nature, vol.394, issue.6696, pp.894-901, 1998.
DOI : 10.1038/29788

R. Menghini, L. Fiorentino, R. Amoruso, A. Mauriello, D. Lauro et al., Tissue Inhibitor of Metalloproteinase 3 Deficiency Causes Hepatic Steatosis and Adipose Tissue Inflammation in Mice, e4. [8] Serino M, pp.663-72, 2007.
DOI : 10.1053/j.gastro.2008.10.079

A. Piccin, W. Murphy, and O. Smith, Circulating microparticles: pathophysiology and clinical implications, Blood Reviews, vol.21, issue.3, pp.157-71, 2007.
DOI : 10.1016/j.blre.2006.09.001

B. Goichot, L. Grunebaum, D. Desprez, S. Vinzio, L. Meyer et al., Circulating procoagulant microparticles in obesity, Diabetes & Metabolism, vol.32, issue.1, pp.82-87, 2006.
DOI : 10.1016/S1262-3636(07)70251-3

C. Heiss, N. Amabile, A. Lee, W. Real, S. Schick et al., Brief Secondhand Smoke Exposure Depresses Endothelial Progenitor Cells Activity and Endothelial Function, Journal of the American College of Cardiology, vol.51, issue.18, pp.1760-71, 2008.
DOI : 10.1016/j.jacc.2008.01.040

S. Nomura, S. Kanazawa, and S. Fukuhara, Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus, Journal of Human Hypertension, vol.16, issue.8, pp.539-586, 2002.
DOI : 10.1038/sj.jhh.1001447

F. Sabatier, P. Darmon, B. Hugel, V. Combes, M. Sanmarco et al., Type 1 And Type 2 Diabetic Patients Display Different Patterns of Cellular Microparticles, Diabetes, vol.51, issue.9, pp.2840-2845, 2002.
DOI : 10.2337/diabetes.51.9.2840

L. Bernal-mizrachi, W. Jy, J. Jimenez, J. Pastor, L. Mauro et al., High levels of circulating endothelial microparticles in patients with acute coronary syndromes, American Heart Journal, vol.145, issue.6, pp.962-70, 2003.
DOI : 10.1016/S0002-8703(03)00103-0

A. Leroyer, H. Isobe, G. Lesèche, Y. Castier, M. Wassef et al., Cellular Origins and Thrombogenic Activity of Microparticles Isolated From Human Atherosclerotic Plaques, Journal of the American College of Cardiology, vol.49, issue.7, pp.772-779, 2007.
DOI : 10.1016/j.jacc.2006.10.053

M. Kornek, Y. Popov, T. Libermann, N. Afdhal, and D. Schuppan, Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells, Hepatology, vol.136, issue.1, pp.230-272, 2011.
DOI : 10.1002/hep.23999

S. Brodsky, M. Facciuto, D. Heydt, J. Chen, H. Islam et al., Dynamics of circulating microparticles in liver transplant patients, J Gastrointestin Liver Dis, vol.17, pp.261-269, 2008.

K. Sturk-maquelin, R. Nieuwland, F. Romijn, L. Eijsman, C. Hack et al., Pro- and non-coagulant forms of non-cell-bound tissue factor in vivo, Journal of Thrombosis and Haemostasis, vol.99, issue.9, pp.1920-1926, 2003.
DOI : 10.1080/140174302762659076

M. Mesri and D. Altieri, Leukocyte Microparticles Stimulate Endothelial Cell Cytokine Release and Tissue Factor Induction in a JNK1 Signaling Pathway, Journal of Biological Chemistry, vol.274, issue.33, pp.23111-23119, 1999.
DOI : 10.1074/jbc.274.33.23111

A. Leroyer, P. Rautou, J. Silvestre, Y. Castier, G. Lesèche et al., CD40 Ligand+ Microparticles From Human Atherosclerotic Plaques Stimulate Endothelial Proliferation and Angiogenesis, Journal of the American College of Cardiology, vol.52, issue.16, pp.1302-1313, 2008.
DOI : 10.1016/j.jacc.2008.07.032

A. Agouni, A. Lagrue-lak-hal, P. Ducluzeau, H. Mostefai, C. Draunet-busson et al., Endothelial Dysfunction Caused by Circulating Microparticles from Patients with Metabolic Syndrome, The American Journal of Pathology, vol.173, issue.4, pp.1210-1219, 2008.
DOI : 10.2353/ajpath.2008.080228

K. Esposito, M. Ciotola, and D. Giugliano, Pioglitazone Reduces Endothelial Microparticles in the Metabolic Syndrome, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.8, 1926.
DOI : 10.1161/01.ATV.0000231512.15115.25

S. Nomura, A. Shouzu, S. Omoto, M. Nishikawa, and T. Iwasaka, Effects of Losartan and Simvastatin on Monocyte-Derived Microparticles in Hypertensive Patients With and Without Type 2 Diabetes Mellitus, Clinical and Applied Thrombosis/Hemostasis, vol.10, issue.2, pp.133-174, 2004.
DOI : 10.1177/107602960401000203

P. Lefebvre, G. Chinetti, J. Fruchart, and B. Staels, Sorting out the roles of PPAR?? in energy metabolism and vascular homeostasis, Journal of Clinical Investigation, vol.116, issue.3, pp.571-80, 2006.
DOI : 10.1172/JCI27989DS1

N. Hennuyer, A. Tailleux, G. Torpier, H. Mezdour, J. Fruchart et al., PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia

R. Srivastava, R. Jahagirdar, S. Azhar, S. Sharma, and C. Bisgaier, Peroxisome proliferator-activated receptor-?? selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice, Molecular and Cellular Biochemistry, vol.107, issue.1-2, pp.35-50, 2006.
DOI : 10.1007/s11010-005-9053-y

H. Duez, Y. Chao, M. Hernandez, G. Torpier, P. Poulain et al., Reduction of Atherosclerosis by the Peroxisome Proliferator-activated Receptor ?? Agonist Fenofibrate in Mice, Journal of Biological Chemistry, vol.277, issue.50, pp.48051-48058, 2002.
DOI : 10.1074/jbc.M206966200

B. Staels, M. Maes, and A. Zambon, Fibrates and future PPAR?? agonists in the treatment of cardiovascular disease, Nature Clinical Practice Cardiovascular Medicine, vol.99, issue.9, pp.542-53, 2008.
DOI : 10.1038/ncpcardio1278

M. Jun, C. Foote, J. Lv, B. Neal, A. Patel et al., Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis, The Lancet, vol.375, issue.9729, pp.1875-84, 2010.
DOI : 10.1016/S0140-6736(10)60656-3

R. Shiri-sverdlov, K. Wouters, V. Gorp, P. Gijbels, M. Noel et al., Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates, Journal of Hepatology, vol.44, issue.4, pp.732-773, 2006.
DOI : 10.1016/j.jhep.2005.10.033

P. Sullivan, H. Mezdour, S. Quarfordt, and N. Maeda, Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2., Journal of Clinical Investigation, vol.102, issue.1, pp.130-135, 1998.
DOI : 10.1172/JCI2673

S. Lee, T. Pineau, J. Drago, E. Lee, J. Owens et al., Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators., Molecular and Cellular Biology, vol.15, issue.6, pp.3012-3034, 1995.
DOI : 10.1128/MCB.15.6.3012

N. Amabile, A. Guérin, A. Leroyer, Z. Mallat, C. Nguyen et al., Circulating Endothelial Microparticles Are Associated with Vascular Dysfunction in Patients with End-Stage Renal Failure, Journal of the American Society of Nephrology, vol.16, issue.11, pp.3381-3389, 2005.
DOI : 10.1681/ASN.2005050535

K. Woollard and F. Geissmann, Monocytes in atherosclerosis: subsets and functions, Nature Reviews Cardiology, vol.4, issue.2, pp.77-86, 2010.
DOI : 10.1038/nrcardio.2009.228

K. Ravichandran and U. Lorenz, Engulfment of apoptotic cells: signals for a good meal, Nature Reviews Immunology, vol.1585, issue.12, pp.964-74, 2007.
DOI : 10.1038/nri2214

I. Tabas, Macrophage Apoptosis in Atherosclerosis: Consequences on Plaque Progression and the Role of Endoplasmic Reticulum Stress, Antioxidants & Redox Signaling, vol.11, issue.9, pp.2333-2342, 2009.
DOI : 10.1089/ars.2009.2469

H. Ait-oufella, K. Kinugawa, J. Zoll, T. Simon, J. Boddaert et al., Lactadherin Deficiency Leads to Apoptotic Cell Accumulation and Accelerated Atherosclerosis in Mice, Circulation, vol.115, issue.16, pp.2168-77, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.662080

A. Li, C. Binder, A. Gutierrez, K. Brown, C. Plotkin et al., Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPAR??, ??/??, and ??, Journal of Clinical Investigation, vol.114, issue.11, pp.1564-76, 2004.
DOI : 10.1172/JCI18730

C. Day and O. James, Steatohepatitis: A tale of two ???hits????, Gastroenterology, vol.114, issue.4, pp.842-847, 1998.
DOI : 10.1016/S0016-5085(98)70599-2